Evidence map›Paper›PMID 31620961›Full record

ArticleJournal of muscle research and cell motility2020

Sarcomeric myopathies associated with tremor: new insights and perspectives.

Janis Stavusis, Janelle Geist, Aikaterini Kontrogianni-Konstantopoulos

Open access · greenAbstract read
In one paragraph

Article in Journal of muscle research and cell motility, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Frontiers in genetics · 2026
    Article
  2. Tremor pathophysiology.Clinical parkinsonism & related disorders · 2026
    Review
  3. Article
  4. Review
  5. Electrophysiological Characterization of aMovement disorders clinical practice · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

Janis StavusisLatvian Biomedical Research and Study Centre, Ratsupites 1, Riga, LV-1067, Latvia.
Janelle GeistDept. of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 N. Greene Street, Baltimore, MD, 21201, USA.
Aikaterini Kontrogianni-KonstantopoulosDept. of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 N. Greene Street, Baltimore, MD, 21201, USA. akontrogianni@som.umaryland.edu.ORCID 0000-0003-3948-1959
University of Maryland, Baltimore · US

Funding

Interdisciplinary Training Program Muscle BiologyT32AR007592 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI Aikaterini Kontrogianni-Konstantopoulos · 1996 to 2026
$11.7M
Novel MYBPC1 mutations cosegregate with a myopathy associated with muscle weakness, hypotonia and tremorR01AR076373 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI KONTROGIANNI-KONSTANTOPOULOS, AIKATERINI · 2020 to 2024
$2.0M
Regulation of MyBP-C slow via phosphorylation in skeletal musclesR21AR072981 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI KONTROGIANNI-KONSTANTOPOULOS, AIKATERINI · 2018 to 2019
$374k
NIAMS NIH HHS R01 AR076373NIAMS NIH HHS R21 AR072981NIAMS NIH HHS T32 AR007592
6 · The paper itself

Abstract

Myopathies are a large and heterogeneous group of disorders associated with mutations in structural and regulatory genes responsible for proper muscle assembly, organization and function. Despite the molecular diversity of inherited myopathies, they have historically been classified by the phenotypic traits observed in affected patients. It is therefore common for myopathies originating from mutations in different genes to be grouped together due to similar physical manifestations, and conversely myopathies resulting from mutations in the same gene to be considered separately due to disparate symptoms. Herein, we focus on an early onset myopathy linked to inherited or de novo mutations in sarcomeric genes that is characterized by muscle weakness, hypotonia and tremor, and further highlight that it may constitute a new form of myopathy, with tremor as its defining feature. Based on recent reports, we also discuss the possible myogenic origin of the tremor that may start at the level of the sarcomere due to structural and/or contractile alterations occurring as a result of the identified mutations. It is our hope that establishment of this form of myopathy accompanied by myogenic tremor as a new disease entity will have important diagnostic and therapeutic implications.

Indexed as

AnimalsDisease Models, AnimalHumansMuscular DiseasesSarcomeresSwineTremorCongenital myopathyHypotoniaMuscle weaknessSarcomeric genesTremor

Identifiers

PMID31620961
PMCPMC7160001
OpenAlexW2981264013

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.